mll重排中的复制应力

M. Milyavsky, B. Gole, L. Wiesmüller
{"title":"mll重排中的复制应力","authors":"M. Milyavsky, B. Gole, L. Wiesmüller","doi":"10.18632/ONCOSCIENCE.281","DOIUrl":null,"url":null,"abstract":"Hematopoietic stem cells (HSC) are the only cells capable of self-renewal throughout the individual's lifetime and generate the whole spectrum of blood cells. Therefore genome aberrations in HSC can result in hematopoiesis failure or leukemic transformation. Chromosomal translocations, inversions, amplifications and complex rearrangements at the 11q human genomic locus encoding mixed lineage leukemia gene (MLL) are the hallmark of several blood malignancies including infant, therapy-induced, donor - and de novo leukemias. The vast majority of these 11q aberrations fall within a 7.3kb MLL breakpoint cluster region (MLLbcr) with a particular hotspot at the intron11-exon12 boundary [1]. Intriguingly, a large variety of genotoxic, cytotoxic and biological stimuli were connected with MLLbcr breakage pointing to the existence of several DNA cleavage and repair mechanisms acting at this locus [1, 2]. From the broad spectrum of stimuli triggering cleavage in concert with diverse mutagenic outcomes at the locus it is tempting to seek for a common molecular process engaged. \n \nBased on our and others’ experimental evidences, we postulate that replication stress in HSC can be responsible for MLL rearrangements (Figure ​(Figure1).1). Thus, our data revealed MLLbcr breakage upon mere replication blockage via DNA polymerase inhibition or upon exposure to the nucleoside analog 5-fluorouracil [2]. Induction of HSC's specific replication stress can be linked to many agents and conditions implicated in MLL leukemias. Normally, quiescence of HSC with only rare replication cycles accompanied by low metabolic activity and ROS levels contributes to minimize the mutational load under homeostatic conditions [3, 4]. In contrast, forcing HSC into excessive cycling by chronic stimulation with physiological triggers mimicking inflammation, bleeding or cytopenia provokes a robust DDR that drives both HSC death and mutagenesis of the survivors. Thus, Walter et al. [4] detected DDR markers associated with replication fork stalling and collapse such as DNA breaks and nuclear γ H2AX, 53BP1 and FANCD2 foci upon enforced HSC exit from quiescence. Transplantation induces rapid cycling of normally dormant HSC that can be exacerbated by donor immunosuppression, damaged microenvironment and altered cytokine profile. Signs of endogenous DNA damage upon serial transplantation of HSC are well documented in both humans and mice with evidence for altered DNA replication dynamics, chromosome gaps and breaks indicative of replication stress [3, 5]. We suggest that exhaustion or failure of replication stress-associated high fidelity repair pathways under transplantation challenge can be implicated in donor cell-derived acute leukemia with MLL translocations in patients who received HSC transplant [6]. Given the fact that replication stress in HSC is associated with aging [3] one can hypothesize that MLL rearrangements, particularly amplifications often associated with complex rearrangements [7], observed in de novo AML in the elderly are the consequence of replication stress associated DNA repair failures. \n \n \n \nFigure 1 \n \nMLL rearrangements can result from failure to correctly resolve replication stress in HSC \n \n \n \nInduction of replication stress in HSC can also be linked to agents and conditions associated with common solid cancer therapies. Indeed, topoisomerase II inhibitors and cytostatics with a different mode-of-action such as alkylating agents or 5-fluorouracil [1, 8] but all implicated in the etiology of therapy-induced leukemia or MLL rearrangements can recruit dormant HSC into the replication cycle as a result of chemotherapy-associated cytopenia. Moreover, fetal HSC which are the infant leukemia cell-of-origin are highly cycling populations and thus collision of replication forks with lesions can cause overwhelming replicative stress. Altogether, replication stress may represent the integrating signal in HSC following genotoxic exposure of the fetus and of patients undergoing radio- or chemotherapy, in HSC undergoing excessive self-renewal in the fetus or upon transplantation as well as in HSC from aged individuals suffering from the exhaustion of replication factors [3]. The extraordinary susceptibility of the MLLbcr to replication stress-induced breakage may stem from its secondary structure resulting in the collision of transcription and replication machineries recruiting nucleases such as Endonuclease G in decondensed chromatin [1](Figure ​](Figure11). \n \nTo summarize, replication stress response plays a key role in regulating HSC function. We anticipate that deeper understanding of associated molecular mechanisms responsible for MLLbcr cleavage and subsequent repair in HSC can hold the key for future chemoprevention and anti-aging modalities.","PeriodicalId":94164,"journal":{"name":"Oncoscience","volume":"12 1","pages":"938 - 939"},"PeriodicalIF":0.0000,"publicationDate":"2015-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Replication stress in MLL-rearrangements\",\"authors\":\"M. Milyavsky, B. Gole, L. Wiesmüller\",\"doi\":\"10.18632/ONCOSCIENCE.281\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hematopoietic stem cells (HSC) are the only cells capable of self-renewal throughout the individual's lifetime and generate the whole spectrum of blood cells. Therefore genome aberrations in HSC can result in hematopoiesis failure or leukemic transformation. Chromosomal translocations, inversions, amplifications and complex rearrangements at the 11q human genomic locus encoding mixed lineage leukemia gene (MLL) are the hallmark of several blood malignancies including infant, therapy-induced, donor - and de novo leukemias. The vast majority of these 11q aberrations fall within a 7.3kb MLL breakpoint cluster region (MLLbcr) with a particular hotspot at the intron11-exon12 boundary [1]. Intriguingly, a large variety of genotoxic, cytotoxic and biological stimuli were connected with MLLbcr breakage pointing to the existence of several DNA cleavage and repair mechanisms acting at this locus [1, 2]. From the broad spectrum of stimuli triggering cleavage in concert with diverse mutagenic outcomes at the locus it is tempting to seek for a common molecular process engaged. \\n \\nBased on our and others’ experimental evidences, we postulate that replication stress in HSC can be responsible for MLL rearrangements (Figure ​(Figure1).1). Thus, our data revealed MLLbcr breakage upon mere replication blockage via DNA polymerase inhibition or upon exposure to the nucleoside analog 5-fluorouracil [2]. Induction of HSC's specific replication stress can be linked to many agents and conditions implicated in MLL leukemias. Normally, quiescence of HSC with only rare replication cycles accompanied by low metabolic activity and ROS levels contributes to minimize the mutational load under homeostatic conditions [3, 4]. In contrast, forcing HSC into excessive cycling by chronic stimulation with physiological triggers mimicking inflammation, bleeding or cytopenia provokes a robust DDR that drives both HSC death and mutagenesis of the survivors. Thus, Walter et al. [4] detected DDR markers associated with replication fork stalling and collapse such as DNA breaks and nuclear γ H2AX, 53BP1 and FANCD2 foci upon enforced HSC exit from quiescence. Transplantation induces rapid cycling of normally dormant HSC that can be exacerbated by donor immunosuppression, damaged microenvironment and altered cytokine profile. Signs of endogenous DNA damage upon serial transplantation of HSC are well documented in both humans and mice with evidence for altered DNA replication dynamics, chromosome gaps and breaks indicative of replication stress [3, 5]. We suggest that exhaustion or failure of replication stress-associated high fidelity repair pathways under transplantation challenge can be implicated in donor cell-derived acute leukemia with MLL translocations in patients who received HSC transplant [6]. Given the fact that replication stress in HSC is associated with aging [3] one can hypothesize that MLL rearrangements, particularly amplifications often associated with complex rearrangements [7], observed in de novo AML in the elderly are the consequence of replication stress associated DNA repair failures. \\n \\n \\n \\nFigure 1 \\n \\nMLL rearrangements can result from failure to correctly resolve replication stress in HSC \\n \\n \\n \\nInduction of replication stress in HSC can also be linked to agents and conditions associated with common solid cancer therapies. Indeed, topoisomerase II inhibitors and cytostatics with a different mode-of-action such as alkylating agents or 5-fluorouracil [1, 8] but all implicated in the etiology of therapy-induced leukemia or MLL rearrangements can recruit dormant HSC into the replication cycle as a result of chemotherapy-associated cytopenia. Moreover, fetal HSC which are the infant leukemia cell-of-origin are highly cycling populations and thus collision of replication forks with lesions can cause overwhelming replicative stress. Altogether, replication stress may represent the integrating signal in HSC following genotoxic exposure of the fetus and of patients undergoing radio- or chemotherapy, in HSC undergoing excessive self-renewal in the fetus or upon transplantation as well as in HSC from aged individuals suffering from the exhaustion of replication factors [3]. The extraordinary susceptibility of the MLLbcr to replication stress-induced breakage may stem from its secondary structure resulting in the collision of transcription and replication machineries recruiting nucleases such as Endonuclease G in decondensed chromatin [1](Figure ​](Figure11). \\n \\nTo summarize, replication stress response plays a key role in regulating HSC function. We anticipate that deeper understanding of associated molecular mechanisms responsible for MLLbcr cleavage and subsequent repair in HSC can hold the key for future chemoprevention and anti-aging modalities.\",\"PeriodicalId\":94164,\"journal\":{\"name\":\"Oncoscience\",\"volume\":\"12 1\",\"pages\":\"938 - 939\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-12-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncoscience\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18632/ONCOSCIENCE.281\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncoscience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18632/ONCOSCIENCE.281","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

摘要

造血干细胞(HSC)是唯一能够在个体一生中自我更新的细胞,并产生整个血细胞谱。因此,造血干细胞基因组畸变可导致造血失败或白血病转化。编码混合谱系白血病基因(MLL)的11q人类基因组位点的染色体易位、倒位、扩增和复杂重排是几种血液恶性肿瘤的标志,包括婴儿白血病、治疗诱导白血病、供体白血病和新生白血病。这些11q畸变绝大多数位于7.3kb的MLL断点簇区域(MLLbcr)内,在intron11-exon12边界处具有特定的热点[1]。有趣的是,大量的基因毒性、细胞毒性和生物刺激与MLLbcr断裂有关,这表明存在几种作用于该位点的DNA切割和修复机制[1,2]。从广泛的刺激触发切割,并在基因座上产生不同的诱变结果,寻求一个共同的分子过程是很有吸引力的。根据我们和其他人的实验证据,我们假设HSC中的复制应激可能是MLL重排的原因(图(图1))。因此,我们的数据显示,MLLbcr仅在DNA聚合酶抑制或暴露于核苷类似物5-氟尿嘧啶时发生复制阻断而断裂[2]。诱导HSC的特异性复制应激可能与许多与MLL白血病相关的因子和条件有关。正常情况下,静止的HSC只有很少的复制周期,伴随着较低的代谢活性和ROS水平,有助于在稳态条件下将突变负荷降至最低[3,4]。相反,通过模拟炎症、出血或细胞减少等生理触发因素的慢性刺激迫使HSC过度循环,会引发强大的DDR,从而驱动HSC死亡和幸存者的突变。因此,Walter等人[4]在强制HSC退出静止状态时检测到与复制叉停滞和崩溃相关的DDR标记,如DNA断裂和核γ H2AX、53BP1和FANCD2聚焦。移植诱导正常休眠的HSC快速循环,供体免疫抑制、微环境受损和细胞因子谱改变会加剧这种循环。在人类和小鼠的造血干细胞连续移植中,内源性DNA损伤的迹象都得到了充分的证明,有证据表明DNA复制动力学改变,染色体间隙和断裂表明复制应激[3,5]。我们认为,移植挑战下复制应激相关高保真修复途径的衰竭或失败可能与接受HSC移植的患者供体细胞源性急性白血病伴MLL易位有关[6]。鉴于HSC中的复制应激与衰老有关[3],我们可以假设,在老年新生AML中观察到的MLL重排,特别是与复杂重排相关的扩增[7],是复制应激相关DNA修复失败的结果。图1 MLL重排可能是由于未能正确解决HSC中的复制应激导致的,HSC中复制应激的诱导也可能与常见实体癌治疗相关的药物和条件有关。事实上,拓扑异构酶II抑制剂和细胞抑制剂具有不同的作用模式,如烷基化剂或5-氟尿嘧啶[1,8],但都与治疗性白血病或MLL重排的病因有关,它们都可以由于化疗相关的细胞减少而将休眠的HSC招募到复制周期中。此外,作为婴儿白血病起源细胞的胎儿HSC是高度循环的群体,因此复制分叉与病变的碰撞可能导致压倒性的复制应激。总之,复制应激可能是胎儿和放疗或化疗患者基因毒性暴露后的HSC、胎儿自我更新过度的HSC或移植后的HSC以及复制因子耗尽的老年人的HSC中的整合信号[3]。MLLbcr对复制应力诱导的断裂异常易感性可能源于其二级结构,导致转录和复制机制碰撞,招募核酸酶,如去致密染色质中的内切酶G[1](图11)。综上所述,复制应激反应在调节HSC功能中起着关键作用。我们预计,对HSC中MLLbcr切割和随后修复的相关分子机制的更深入了解可以为未来的化学预防和抗衰老模式提供关键。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Replication stress in MLL-rearrangements
Hematopoietic stem cells (HSC) are the only cells capable of self-renewal throughout the individual's lifetime and generate the whole spectrum of blood cells. Therefore genome aberrations in HSC can result in hematopoiesis failure or leukemic transformation. Chromosomal translocations, inversions, amplifications and complex rearrangements at the 11q human genomic locus encoding mixed lineage leukemia gene (MLL) are the hallmark of several blood malignancies including infant, therapy-induced, donor - and de novo leukemias. The vast majority of these 11q aberrations fall within a 7.3kb MLL breakpoint cluster region (MLLbcr) with a particular hotspot at the intron11-exon12 boundary [1]. Intriguingly, a large variety of genotoxic, cytotoxic and biological stimuli were connected with MLLbcr breakage pointing to the existence of several DNA cleavage and repair mechanisms acting at this locus [1, 2]. From the broad spectrum of stimuli triggering cleavage in concert with diverse mutagenic outcomes at the locus it is tempting to seek for a common molecular process engaged. Based on our and others’ experimental evidences, we postulate that replication stress in HSC can be responsible for MLL rearrangements (Figure ​(Figure1).1). Thus, our data revealed MLLbcr breakage upon mere replication blockage via DNA polymerase inhibition or upon exposure to the nucleoside analog 5-fluorouracil [2]. Induction of HSC's specific replication stress can be linked to many agents and conditions implicated in MLL leukemias. Normally, quiescence of HSC with only rare replication cycles accompanied by low metabolic activity and ROS levels contributes to minimize the mutational load under homeostatic conditions [3, 4]. In contrast, forcing HSC into excessive cycling by chronic stimulation with physiological triggers mimicking inflammation, bleeding or cytopenia provokes a robust DDR that drives both HSC death and mutagenesis of the survivors. Thus, Walter et al. [4] detected DDR markers associated with replication fork stalling and collapse such as DNA breaks and nuclear γ H2AX, 53BP1 and FANCD2 foci upon enforced HSC exit from quiescence. Transplantation induces rapid cycling of normally dormant HSC that can be exacerbated by donor immunosuppression, damaged microenvironment and altered cytokine profile. Signs of endogenous DNA damage upon serial transplantation of HSC are well documented in both humans and mice with evidence for altered DNA replication dynamics, chromosome gaps and breaks indicative of replication stress [3, 5]. We suggest that exhaustion or failure of replication stress-associated high fidelity repair pathways under transplantation challenge can be implicated in donor cell-derived acute leukemia with MLL translocations in patients who received HSC transplant [6]. Given the fact that replication stress in HSC is associated with aging [3] one can hypothesize that MLL rearrangements, particularly amplifications often associated with complex rearrangements [7], observed in de novo AML in the elderly are the consequence of replication stress associated DNA repair failures. Figure 1 MLL rearrangements can result from failure to correctly resolve replication stress in HSC Induction of replication stress in HSC can also be linked to agents and conditions associated with common solid cancer therapies. Indeed, topoisomerase II inhibitors and cytostatics with a different mode-of-action such as alkylating agents or 5-fluorouracil [1, 8] but all implicated in the etiology of therapy-induced leukemia or MLL rearrangements can recruit dormant HSC into the replication cycle as a result of chemotherapy-associated cytopenia. Moreover, fetal HSC which are the infant leukemia cell-of-origin are highly cycling populations and thus collision of replication forks with lesions can cause overwhelming replicative stress. Altogether, replication stress may represent the integrating signal in HSC following genotoxic exposure of the fetus and of patients undergoing radio- or chemotherapy, in HSC undergoing excessive self-renewal in the fetus or upon transplantation as well as in HSC from aged individuals suffering from the exhaustion of replication factors [3]. The extraordinary susceptibility of the MLLbcr to replication stress-induced breakage may stem from its secondary structure resulting in the collision of transcription and replication machineries recruiting nucleases such as Endonuclease G in decondensed chromatin [1](Figure ​](Figure11). To summarize, replication stress response plays a key role in regulating HSC function. We anticipate that deeper understanding of associated molecular mechanisms responsible for MLLbcr cleavage and subsequent repair in HSC can hold the key for future chemoprevention and anti-aging modalities.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信